Invicro
Clinical trials sponsored by Invicro, explained in plain language.
-
New brain scan could spot Parkinson's early
Diagnosis Recruiting nowThis study tests a new imaging drug called [18F]MK-0947 that works with a PET scan to show clumps of a protein linked to Parkinson's disease in the brain. Researchers want to see if it is safe and can help diagnose Parkinson's or track its progression. The study involves about 22…
Phase: EARLY_PHASE1 • Sponsor: Invicro • Aim: Diagnosis
Last updated Jun 15, 2026 19:05 UTC
-
New imaging agents could spot rare brain disease earlier
Diagnosis Recruiting nowThis study tests two new imaging drugs, [18F]ABBV-964i and [18F]ABBV-965i, used with PET scans to see tau protein buildup in the brain, which is linked to Progressive Supranuclear Palsy (PSP). The main goals are to check safety and how well these drugs show tau in the brain. Abou…
Phase: EARLY_PHASE1 • Sponsor: Invicro • Aim: Diagnosis
Last updated Jun 09, 2026 12:10 UTC